Webster Equity Partners agrees to buy Lifecore Biomedical for up to $663.7 million
Lifecore Biomedical Target · Webster Equity Partners Acquirer
Intelligence
The deal
- Type
- Buyout
- Amount
- up to $663.7M
- Structure
- $6.28 per share in cash plus one non-tradable contingent value right per share
- Status
- Announced
- Valuation
- Not recorded
- Region
- United States
- Date
- 28 September 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
Lifecore Biomedical Target
Webster Equity Partners Acquirer
Activity